CompletedNot Applicable

Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome

France20 participantsStarted 2024-02-15

Plain-language summary

The aim of the study is to see if endogenous exhaled Nitric Oxyde (eNO) concentrations measured are significantly higher in ARDS patients admitted in ICU ; compared to control subjects in good health with no lung disease or global inflammation, operated under general anesthesia (i.e. intubated and ventilated) for thyroid or parathyroid.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * For ARDS patients : * Patients with ARDS (according to the Berlin criteria) admitted in intensive care unit and intubated for less than 24 hours. * For control patients : * Patients with no major disease (classified 1 or 2 in the classification of the American Society of Anaesthesiology) * Patients undergoing general anaesthesia for a thyroïd or parathyroïd surgery Exclusion Criteria: * Minors under the age of 18 years old * Pregnant women * prisoners * patients who have withdrawn their consent.

What they're measuring

Endogenous exhaled Nitric Oxyde (eNO)

Timeframe: Measurement of eNO over a period of 10 minutes just after induction of anesthesia

Trial details

NCT IDNCT06250348

SponsorUniversity Hospital, Grenoble

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More ARDS, Human trials